Finally, we identified and validated RBM5 as an aberrant RNA binder in models of HD, explaining changes observed in alternative splicing for this disease and demonstrating the utility of our approach to study RBP function in neurodegenerative disorders. Here, RBM5 is linked to Huntington disease.